Clinical, electroencephalographical and neuropharmacological studies in syndromes of progressive myoclonus epilepsy.
D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000654:Amobarbital / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use; D002697:Chloral Hydrate / Q000627:therapeutic use; D002719:Chlormethiazole / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D002749:Chlorprothixene / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D004569:Electroencephalography; D004576:Electromyography; D004830:Epilepsy, Tonic-Clonic / Q000150:complications* / Q000188:drug therapy*; D000431:Ethanol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008615:Mephenesin / Q000627:therapeutic use; D009207:Myoclonus / Q000150:complications* / Q000188:drug therapy*; D010634:Phenobarbital / Q000627:therapeutic use; D012890:Sleep; D013390:Succinylcholine / Q000627:therapeutic use
D001552:Benzazepines; D002719:Chlormethiazole; D000431:Ethanol; D002697:Chloral Hydrate; D008615:Mephenesin; D000324:Adrenocorticotropic Hormone; D008012:Lidocaine; D002749:Chlorprothixene; D000654:Amobarbital; D013390:Succinylcholine; D003975:Diazepam; D002746:Chlorpromazine; D010634:Phenobarbital